Elpamotide

Elpamotide is an epitope peptide derived from VEGFR2. Elpamotide induces cytotoxic T lymphocytes (CTL) to kill VEGFR2-expressing endothelial cells. Elpamotide has potential immunostimulatory and antitumor activity. Ipamotide is used in cancer research, such as pancreatic cancer.

• Supplier: Alfa Cytology
• Product #: PC0191